close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Filter Results By

Filter Applied. Clear All
Reset All Filters

Search Results for: Covid vacc

What you need to know about the COVID-19 vaccines

CLI’s analysis found that a majority of vaccine candidates did not use abortion-derived cell lines in their production. Several used abortion-derived cell lines in laboratory testing, or their use in testing could not be determined. Experts urge all vaccine developers to use noncontroversial alternatives.

Update: COVID-19 Vaccine Candidates and Abortion-Derived Cell Lines

Accurate information about the development and production of COVID-19 vaccines is essential, especially because many proposed candidates use newer molecular technologies for production of a viral vaccine.  One concern regarding the ethical assessment of viral vaccine candidates is the potential use of abortion-derived cell lines in the development, production or testing of a vaccine.  This analysis utilizes data from the primary scientific literature when available, along with data from clinical trial documents, reputable vaccine tracking websites, and published commercial information.1  It is the hope that by providing accurate data, recipients can make well-informed decisions regarding vaccine choices.

An Ethics Assessment of COVID-19 Vaccine Programs

Adherence to the highest ethical standards in science and medicine serves all humanity, because it values the dignity of every human life and respects the consciences of all, without exploitation of any group.

Pro-Life Scientists: Facts You Should Know About FDA-Approved Pfizer Vaccine

Today, the Food and Drug Administration (FDA) granted full approval for the Pfizer/BioNTech COVID-19 vaccine.  Scientists and researchers at the Charlotte Lozier Institute (CLI) have been studying the Pfizer vaccine from a pro-life perspective since March 2020.

CLI Statement on Johnson & Johnson Vaccine: Abortion-Derived Cell Lines Used in Production Process

“For many Americans, the approval of Johnson & Johnson’s vaccine raises renewed questions about the use of cells derived from elective abortions. Many leading vaccine candidates supported by Operation Warp Speed, including the approved vaccines produced by Pfizer/BioNTech and Moderna, do not use abortion-derived cell lines in their production. Unlike the majority of those candidates, Johnson & Johnson does use these cell lines in the production process.

CLI Analysis: Majority of Operation Warp Speed Vaccines Not Produced Using Abortion-Derived Cells

“CLI’s expert scientific analysis finds that many leading vaccine candidates supported by Operation Warp Speed do not use abortion-derived cell lines in their production. This is encouraging news.

A Visual Aid to Viral Infection and Vaccine Production

As a result of the rapid spread of the new coronavirus technically known as SARS-CoV-2, the United States and other governments have begun crash efforts to create an effective vaccine or vaccines against the illness at “warp speed.”  An array of candidates for this vaccine have emerged and are in various stages of development and testing.  At the same time, questions have emerged about the ways in which these vaccines, reflecting experience across the history of development of these preventives, are produced, including processes to which millions of Americans object on moral grounds.  The variety of means used to produce vaccines today is immense, employing both ethically licit and questionable procedures.  To assist in understanding these modes of production, we offer this primer on the basic science involved.

David Gortler PharmD, FCCP

David Gortler PharmD, FCCP is a scholar at the Ethics and Public Policy Center in Washington, D.C. focusing on FDA oversight and drug safety.  Previously he worked at the U.S. Food and Drug Administration as a Senior Medical Analyst from 2007-2011, and as